Variant report

Variant	nsv1013019
Chromosome Location	chr4:106461690-106501412
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:189)
CpG islands
(count:305)
Chromatin interactive
region (count:18)
LncRNA
region (count:9)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:189 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr4:106476382-106476975	H1-hESC	embryonic stem cell:	n/a	n/a
2	ATF2	chr4:106476296-106476927	H1-hESC	embryonic stem cell:	n/a	n/a
3	BATF	chr4:106493463-106493783	GM12878	blood:	n/a	n/a
4	BCL11A	chr4:106476446-106477001	H1-hESC	embryonic stem cell:	n/a	n/a
5	BCL11A	chr4:106476464-106476911	H1-hESC	embryonic stem cell:	n/a	n/a
6	BRCA1	chr4:106476237-106477133	H1-hESC	embryonic stem cell:	n/a	n/a
7	CEBPB	chr4:106471808-106472196	Hela-S3	cervix:	n/a	n/a
8	CEBPB	chr4:106485558-106485827	HepG2	liver:	n/a	chr4:106485716-106485727
9	CEBPB	chr4:106489734-106490038	HepG2	liver:	n/a	n/a
10	CEBPB	chr4:106468143-106468612	HepG2	liver:	n/a	chr4:106468164-106468175 chr4:106468166-106468177
11	CHD2	chr4:106476478-106476985	H1-hESC	embryonic stem cell:	n/a	n/a
12	CTCF	chr4:106473360-106473510	RPTEC	kidney:	n/a	n/a
13	CTCF	chr4:106473436-106473477	MCF-7	breast:	n/a	n/a
14	CTCF	chr4:106473460-106473610	MCF-7	breast:	n/a	n/a
15	E2F4	chr4:106481823-106482023	MCF10A-Er-Src	breast:	n/a	n/a
16	EBF1	chr4:106469739-106469781	GM12878	blood:	n/a	n/a
17	EP300	chr4:106465540-106466142	SK-N-SH_RA	brain:	n/a	n/a
18	EP300	chr4:106476402-106477021	H1-hESC	embryonic stem cell:	n/a	n/a
19	EP300	chr4:106489913-106490596	T-47D	breast:	n/a	chr4:106490228-106490238
20	EP300	chr4:106470043-106470130	GM12878	blood:	n/a	n/a
21	EP300	chr4:106490159-106490486	T-47D	breast:	n/a	chr4:106490228-106490238
22	EP300	chr4:106465430-106466157	SK-N-SH	brain:	n/a	n/a
23	EP300	chr4:106467323-106467844	SK-N-SH_RA	brain:	n/a	chr4:106467590-106467604
24	EP300	chr4:106465543-106466084	SK-N-SH_RA	brain:	n/a	n/a
25	EP300	chr4:106481432-106482062	SK-N-SH_RA	brain:	n/a	chr4:106481714-106481723 chr4:106481470-106481479
26	EP300	chr4:106472872-106473985	T-47D	breast:	n/a	n/a
27	EP300	chr4:106473058-106473846	T-47D	breast:	n/a	n/a
28	EP300	chr4:106476514-106476887	H1-hESC	embryonic stem cell:	n/a	n/a
29	EP300	chr4:106469606-106470040	SK-N-SH_RA	brain:	n/a	n/a
30	EP300	chr4:106468814-106470014	SK-N-SH	brain:	n/a	n/a
31	EP300	chr4:106465485-106466184	SK-N-SH	brain:	n/a	n/a
32	EP300	chr4:106469609-106470065	SK-N-SH_RA	brain:	n/a	n/a
33	EP300	chr4:106481529-106481933	SK-N-SH_RA	brain:	n/a	chr4:106481714-106481723
34	ESR1	chr4:106473258-106473667	T-47D	breast:	n/a	n/a
35	ESR1	chr4:106476644-106476887	ECC-1	luminal epithelium:	n/a	n/a
36	ESR1	chr4:106473019-106473719	T-47D	breast:	n/a	n/a
37	ESR1	chr4:106490154-106490523	T-47D	breast:	n/a	n/a
38	ESR1	chr4:106473085-106473611	T-47D	breast:	n/a	n/a
39	ESR1	chr4:106476595-106476909	ECC-1	luminal epithelium:	n/a	n/a
40	FOS	chr4:106469667-106469971	MCF10A-Er-Src	breast:	n/a	n/a
41	FOS	chr4:106473080-106473348	MCF10A-Er-Src	breast:	n/a	n/a
42	FOS	chr4:106481587-106482108	MCF10A-Er-Src	breast:	n/a	chr4:106481716-106481723 chr4:106481714-106481723
43	FOS	chr4:106481554-106482074	MCF10A-Er-Src	breast:	n/a	chr4:106481716-106481723 chr4:106481714-106481723
44	FOS	chr4:106469676-106469933	MCF10A-Er-Src	breast:	n/a	n/a
45	FOS	chr4:106481544-106482077	MCF10A-Er-Src	breast:	n/a	chr4:106481716-106481723 chr4:106481714-106481723
46	FOS	chr4:106473064-106473339	MCF10A-Er-Src	breast:	n/a	n/a
47	FOS	chr4:106471821-106472085	MCF10A-Er-Src	breast:	n/a	n/a
48	FOS	chr4:106473202-106473298	MCF10A-Er-Src	breast:	n/a	n/a
49	FOS	chr4:106471858-106472099	MCF10A-Er-Src	breast:	n/a	n/a
50	FOS	chr4:106481600-106482033	MCF10A-Er-Src	breast:	n/a	chr4:106481716-106481723 chr4:106481714-106481723

(count:305 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:106473040-106473090	HMEC	breast:	n/a
2	chr4:106472990-106473040	SKMC	muscle:	n/a
3	chr4:106473233-106473283	HEEpiC	esophagus:	n/a
4	chr4:106473233-106473283	HepG2	liver:	n/a
5	chr4:106472990-106473040	MCF-7	breast:	n/a
6	chr4:106473040-106473090	SK-N-SH	brain:	n/a
7	chr4:106473040-106473090	H1-hESC	embryonic stem cell:	embryo
8	chr4:106472990-106473040	HEEpiC	esophagus:	n/a
9	chr4:106472990-106473040	Jurkat	blood:	n/a
10	chr4:106472990-106473040	T-47D	breast:	n/a
11	chr4:106473806-106473856	PFSK-1	brain:	n/a
12	chr4:106473806-106473856	NB4	blood:	n/a
13	chr4:106473233-106473283	HCPEpiC	choroid plexus:	n/a
14	chr4:106473806-106473856	MCF10A-Er-Src	breast:	n/a
15	chr4:106473040-106473090	HNPCEpiC	eye:	n/a
16	chr4:106473233-106473283	H1-hESC	embryonic stem cell:	embryo
17	chr4:106473040-106473090	HRE	kidney:	n/a
18	chr4:106473040-106473090	ECC-1	luminal epithelium:	n/a
19	chr4:106477599-106477649	HCPEpiC	choroid plexus:	n/a
20	chr4:106473806-106473856	HL-60	blood:	n/a
21	chr4:106473233-106473283	CMK	blood:	n/a
22	chr4:106473806-106473856	MCF-7	breast:	n/a
23	chr4:106473806-106473856	PrEC	prostate:	n/a
24	chr4:106473233-106473283	NHBE	bronchial:	n/a
25	chr4:106473806-106473856	NT2-D1	testis:	n/a
26	chr4:106473806-106473856	K562	blood:	n/a
27	chr4:106473233-106473283	A549	lung:	n/a
28	chr4:106473040-106473090	HPAEpiC	pulmonary alveolar:	n/a
29	chr4:106473233-106473283	AG09309	skin:	n/a
30	chr4:106472990-106473040	NH-A	brain:	n/a
31	chr4:106473040-106473090	RPTEC	kidney:	n/a
32	chr4:106477599-106477649	Jurkat	blood:	n/a
33	chr4:106477599-106477649	GM12892	blood:	n/a
34	chr4:106477599-106477649	HPAEpiC	pulmonary alveolar:	n/a
35	chr4:106473233-106473283	HEK293	kidney:	embryo
36	chr4:106473806-106473856	HCF	heart:	n/a
37	chr4:106477599-106477649	Hela-S3	cervix:	n/a
38	chr4:106473233-106473283	ECC-1	luminal epithelium:	n/a
39	chr4:106477599-106477649	HCF	heart:	n/a
40	chr4:106473040-106473090	PANC-1	pancreas:	n/a
41	chr4:106472990-106473040	A549	lung:	n/a
42	chr4:106472990-106473040	HIPEpiC	eye:	n/a
43	chr4:106472990-106473040	GM19239	blood:	n/a
44	chr4:106477599-106477649	HCT-116	colon:	n/a
45	chr4:106473806-106473856	SAEC	small airway:	n/a
46	chr4:106473233-106473283	HPAEpiC	pulmonary alveolar:	n/a
47	chr4:106477599-106477649	NB4	blood:	n/a
48	chr4:106477599-106477649	SK-N-MC	brain:	n/a
49	chr4:106473040-106473090	Hela-S3	cervix:	n/a
50	chr4:106473806-106473856	AG04449	skin:	fetal

(count:18 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:106474325..106476444-chr4:106476458..106478164,2	MCF-7	breast:
2	chr4:106452636..106454650-chr4:106472579..106474364,2	MCF-7	breast:
3	chr4:106458702..106460921-chr4:106463340..106464931,2	K562	blood:
4	chr4:106470555..106472304-chr4:106504730..106507228,2	MCF-7	breast:
5	chr4:106456619..106459563-chr4:106461731..106463301,3	K562	blood:
6	chr4:106464275..106466669-chr4:106473220..106476149,3	K562	blood:
7	chr4:106493186..106495301-chr4:106506579..106508240,2	K562	blood:
8	chr4:106479363..106481837-chr4:106485512..106487322,2	MCF-7	breast:
9	chr4:106479363..106481837-chr4:106485512..106487322,2	MCF-7	breast:
10	chr4:106467032..106469606-chr4:106472121..106474204,2	MCF-7	breast:
11	chr4:106483518..106485552-chr4:106531782..106533703,2	MCF-7	breast:
12	chr4:106479272..106480860-chr4:106482086..106483907,2	MCF-7	breast:
13	chr4:106492214..106494083-chr4:106533878..106536037,2	MCF-7	breast:
14	chr4:106473806..106476270-chr4:106501097..106503243,2	MCF-7	breast:
15	chr4:106473010..106475476-chr4:106482085..106484725,2	MCF-7	breast:
16	chr4:106471957..106473637-chr4:106475938..106478326,2	MCF-7	breast:
17	chr4:106474325..106476444-chr4:106476458..106478164,2	MCF-7	breast:
18	chr4:106473010..106475476-chr4:106482085..106484725,2	MCF-7	breast:

(count:9 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-GSTCD-1	chr4:106482748-106482804	ENSG00000249885.1
2	lnc-GSTCD-1	chr4:106491061-106491395	ENSG00000249885.1
3	lnc-GSTCD-1	chr4:106484459-106484522	NR_046840
4	lnc-GSTCD-1	chr4:106491061-106491392	NR_046840
5	lnc-GSTCD-1	chr4:106484459-106484522	ENSG00000249885.1
6	lnc-PPA2-2	chr4:106462427-106462559	XLOC_004036
7	lnc-PPA2-2	chr4:106473350-106473512	XLOC_004036
8	lnc-GSTCD-1	chr4:106482748-106482804	NR_046840
9	lnc-PPA2-2	chr4:106463728-106463866	XLOC_004036

No data

Variant related genes	Relation type
ARHGEF38	TF binding region
ENSG00000250522	TF binding region
ARHGEF38-IT1	TF binding region
ARHGEF38	CpG island
ENSG00000250522	CpG island
ARHGEF38-IT1	CpG island
ENSG00000249885	chromatin interactions
ENSG00000236699	chromatin interactions
ENSG00000250522	chromatin interactions
ENSG00000250922	chromatin interactions
SF3A1	miRNA target sites
SLC35D2	miRNA target sites
C16orf48	miRNA target sites

Extended variants
information (count: 1539 )
Associated
traits (count: 78 )

Variant overlapped rSNPs/rCNVs (count:1539 , 50 per page) page: 1 2 3 4 5 6 7 ... 31

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs17035687	chr4:106461690-106461691	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs79619858	chr4:106461705-106461706	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs529051347	chr4:106461801-106461802	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs192920384	chr4:106461806-106461807	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs554949367	chr4:106461859-106461860	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs543753651	chr4:106461889-106461890	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs554522560	chr4:106461893-106461894	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs185245063	chr4:106461916-106461917	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs550953725	chr4:106461945-106461946	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs17584200	chr4:106461954-106461955	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs530431851	chr4:106461956-106461957	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs376956876	chr4:106461959-106461960	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs567268721	chr4:106462006-106462007	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs386678091	chr4:106462046-106462047	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs73837927	chr4:106462047-106462048	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs367776906	chr4:106462142-106462143	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs567161508	chr4:106462195-106462196	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs80048675	chr4:106462207-106462208	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs541685760	chr4:106462232-106462233	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs188162587	chr4:106462257-106462258	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs537869334	chr4:106462315-106462316	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs555019136	chr4:106462316-106462317	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs143919910	chr4:106462344-106462345	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs58098648	chr4:106462356-106462357	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs371998731	chr4:106462372-106462373	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs1018928	chr4:106462377-106462378	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs17617731	chr4:106462420-106462421	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
28	rs572799871	chr4:106462429-106462430	Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
29	rs528210054	chr4:106462441-106462442	Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
30	rs544859617	chr4:106462453-106462454	Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
31	rs369181499	chr4:106462470-106462471	Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
32	rs530495428	chr4:106462517-106462518	Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
33	rs192864042	chr4:106462536-106462537	Enhancers Flanking Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
34	rs75813668	chr4:106462685-106462686	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs115315396	chr4:106462698-106462699	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs1490598	chr4:106462709-106462710	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs567022115	chr4:106462723-106462724	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs539245880	chr4:106462756-106462757	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs552870820	chr4:106462761-106462762	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs143346873	chr4:106462784-106462785	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs538216952	chr4:106462891-106462892	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs1490597	chr4:106462893-106462894	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs373306855	chr4:106462894-106462895	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs533939073	chr4:106462941-106462942	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs142468246	chr4:106462942-106462943	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs534082187	chr4:106462971-106462972	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs553853609	chr4:106463009-106463010	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs78405378	chr4:106463063-106463064	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs183911641	chr4:106463076-106463077	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs34418621	chr4:106463117-106463118	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:78)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Breast cancer	16272173	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Myelodysplastic syndrome	21251322	CNVD
Lung cancer	18438408	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	21183584	CNVD
primary effusion lymphomas	17116491	CNVD
small cell lung cancer	20016488	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	17133270	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	20459617	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Breast cancer	17393978	CNVD
Ovarian cancer	21720365	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Esophageal cancer	21851588	CNVD
Prostate cancer	16573809	CNVD
Multiple myeloma	16616336	CNVD
Melanoma	20688739	CNVD
Breast cancer	16397240	CNVD
Acute myeloid leukemia	18000384	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Myelofibrosis	22110671	CNVD
myeloid cancer	21057493	CNVD
Cognitive impairment	21505072	CNVD
Acute myeloid leukemia	21251322	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:364 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:106448600-106466200	Weak transcription	Pancreas	Pancrea
2	chr4:106458200-106464600	Weak transcription	Gastric	stomach
3	chr4:106461800-106463200	Enhancers	Fetal Intestine Large	intestine
4	chr4:106462000-106462200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
5	chr4:106462000-106463200	Enhancers	Fetal Intestine Small	intestine
6	chr4:106462000-106463800	Enhancers	Primary T cells from cord blood	blood
7	chr4:106462000-106464000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
8	chr4:106462200-106463200	Enhancers	Primary hematopoietic stem cells	blood
9	chr4:106462200-106463800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
10	chr4:106462400-106462600	Enhancers	Small Intestine	intestine
11	chr4:106462400-106463200	Enhancers	Primary hematopoietic stem cells short term culture	blood
12	chr4:106462600-106463600	Weak transcription	Small Intestine	intestine
13	chr4:106462800-106463200	Enhancers	Sigmoid Colon	Sigmoid Colon
14	chr4:106463200-106463600	Weak transcription	Sigmoid Colon	Sigmoid Colon
15	chr4:106463200-106463800	Weak transcription	Primary hematopoietic stem cells short term culture	blood
16	chr4:106463200-106465600	Weak transcription	Fetal Intestine Large	intestine
17	chr4:106463200-106465600	Weak transcription	Fetal Intestine Small	intestine
18	chr4:106463600-106463800	Enhancers	Rectal Mucosa Donor 31	rectum
19	chr4:106463600-106463800	Enhancers	Sigmoid Colon	Sigmoid Colon
20	chr4:106463600-106463800	Enhancers	Small Intestine	intestine
21	chr4:106463800-106464000	Enhancers	Primary hematopoietic stem cells short term culture	blood
22	chr4:106463800-106464000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
23	chr4:106463800-106464600	Weak transcription	Rectal Mucosa Donor 31	rectum
24	chr4:106463800-106465600	Weak transcription	Sigmoid Colon	Sigmoid Colon
25	chr4:106464600-106466400	Enhancers	Rectal Mucosa Donor 31	rectum
26	chr4:106464600-106466600	Enhancers	Cortex derived primary cultured neurospheres	brain
27	chr4:106464600-106471200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
28	chr4:106464800-106465200	Enhancers	Brain Hippocampus Middle	brain
29	chr4:106465000-106465200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
30	chr4:106465200-106465600	Weak transcription	Brain Hippocampus Middle	brain
31	chr4:106465200-106465800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
32	chr4:106465200-106466000	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
33	chr4:106465400-106466000	Enhancers	Rectal Mucosa Donor 29	rectum
34	chr4:106465600-106465800	Enhancers	Brain Substantia Nigra	brain
35	chr4:106465600-106465800	Enhancers	HSMMtube	muscle
36	chr4:106465600-106466000	Enhancers	Sigmoid Colon	Sigmoid Colon
37	chr4:106465600-106466400	Enhancers	Fetal Intestine Small	intestine
38	chr4:106465600-106466600	Enhancers	Fetal Intestine Large	intestine
39	chr4:106465600-106466600	Enhancers	Fetal Kidney	kidney
40	chr4:106465600-106467400	Enhancers	Brain Hippocampus Middle	brain
41	chr4:106465800-106466000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
42	chr4:106465800-106466000	Enhancers	Small Intestine	intestine
43	chr4:106465800-106466400	Enhancers	Brain Anterior Caudate	brain
44	chr4:106465800-106466600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
45	chr4:106465800-106466600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
46	chr4:106466000-106466200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
47	chr4:106466000-106467000	Weak transcription	Brain Substantia Nigra	brain
48	chr4:106466000-106469000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
49	chr4:106466000-106471400	Weak transcription	Rectal Mucosa Donor 29	rectum
50	chr4:106466200-106466600	Enhancers	Duodenum Mucosa	Duodenum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links